Opioid receptor-induced GTPγ35S binding during mouse development

Developmental Biology

Volumn 253, Issue 1, 2003, Pages 99-108

  Nitsche, Joshua F ^a   Pintar, John E ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Development; Embryonic; G protein coupling; GTP 35S binding autoradiography; Opiate; Opioid receptors

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FETUS (ANATOMY); GENE EXPRESSION; HABENULA; HYPOTHALAMUS; MEDULLA OBLONGATA; MESENCEPHALON; MOUSE; NONHUMAN; ONTOGENY; PONS; PRIORITY JOURNAL; TRIGEMINUS GANGLION;

EID: 0037228853     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2002.0855     Document Type: Article

References (47)

1. Berrendero, F., Garcia-Gil, L., Hernandez, M. L., Romero, J., Cebeira, M., de Miguel, R., Ramos, J. A., and Fernandez-Ruiz, J. J. (1998). Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 125, 3179-3188.
2. Bunikowski, R., Grimmer, I., Heiser, A., Metze, B., Schafer, A., and Obladen, M. (1998). Neurodevelopmental outcome after prenatal exposure to opiates. Eur. J. Pediatr. 157, 724-730.
3. Clarke, S., Czyzyk, T., Ansonoff, M. A., Nitsche, J. F., Hsu, M.-S., Nillson, L., Larsson, K., Borsodi, A., Toth, G., Hill, R., Kitchen, I., and Pintar, J. E. (2002). Autoradiographic analysis of naloxone and bremazocine binding in triple KO mice. Eur. J. Neurosci., in press.
4. Eriksson, P. S., Ronnback, L. (1989). Effects of prenatal morphine treatment of rats on mortality, bodyweight and analgesic response in the offspring. Drug Alcohol Depend. 24, 187-194.
5. Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W., Simonin, F., Befort, K., Gaveriaux-Ruff, C., Dierich, A., LeMeur, M., Valverde, O., Maldonado, R., and Kieffer, B. L. (2000). Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat. Genet. 25, 195-200.
6. Ford, D. H., and Rhines, R. K. (1979). Prenatal exposure to methadone HCL in relationship to body and brain growth in the rat. Acta Neurol. Scand. 59, 248-262.
7. Garzon, J., Castro, M. A., Juarros, J. L., and Sanchez-Blazquez, P. (1994). Antibodies raised against the N-terminal sequence of delta opioid receptors blocked delta-mediated supraspinal antinociception in mice. Life Sci. 54, L191-L196.
8. Gaveriaux-Ruff, C., Filliol, D., Simonin, F., Matthes, H. W., and Kieffer, B. L. (2001). Immunosuppression by delta-opioid antagonist naltrindole: Delta- and triple mu/delta/kappa-opioid receptor knockout mice reveal a nonopioid activity. J. Pharmacol. Exp. Ther. 298, 1193-1198.
9. Hilf, G., Gierschik, P., and Jakobs, K. H. (1989). Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186, 725-731.
10. Hutchings, D. E., Zmitrovich, A., Brake, S. C., Malowany, D., Church, S., and Nero, T. J. (1992). Prenatal administration of methadone using the osmotic minipump: Effects on maternal and offspring toxicity, growth, and behavior in the rat. Neurotoxicol. Teratol. 14, 65-71.
11. Ihnatovych, I., Novotny, J., Haugvicova, R., Bourova, L., Maresv, P., and Svoboda, P. (2002). Opposing changes of trimeric G protein levels during ontogenetic development of rat brain. Brain Res. Dev. Brain Res. 133, 57-67.
12. Kent, J. L., Pert, C. B., and Herkenham, M. (1981). Ontogeny of opiate receptors in rat forebrain: Visualization by in vitro autoradiography. Brain Res. 254, 487-504.
13. Kolakowski, L. F., Jr. (1994). GCRDb: A G-protein-coupled receptor database. Receptors Channels 2, 1-7.
14. Kunko, P. M., Smith, J. A., Wallace, M. J., Maher, J. R., Saady, J. J., and Robinson, S. E. (1996). Perinatal methadone exposure produces physical dependence and altered behavioral development in the rat. J. Pharmacol. Exp. Ther. 277, 1344-1351.
15. Lorenzen, A., Fuss, M., Vogt, H., and Schwabe, U. (1993). Measurement of guanine nucleotide-binding protein activation by A1 adenosine receptor agonists in bovine brain membranes: Stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding. Mol. Pharmacol. 44, 115-123.
16. Lucien, C., and Crutcher, M. D. (1991). The basal ganglia. In "Principles of Neural Science," 3rd Edition (E. R. Kandel, J. H. Schwartz, and T. M. Jessell, Eds.), pp. 647-659. Elsevier, New York.
17. Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., and Watson, S. J. (1994). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study. J. Comp. Neurol. 350, 412-438.
18. Matsuda, A. Y., and Olsen, G. D. (2001). Chronic in utero morphine exposure alters mu-agonist-stimulated [35S]- GTPgammaS binding in neonatal and juvenile guinea pig brainstem regions associated with breathing control. Neurotoxicol. Teratol. 23, 413-419.
19. McLaughlin, P. J., Tobias, S. W., Lang, C. M., and Zagon, I. S. (1997a). Opioid receptor blockade during prenatal life modifies postnatal behavioral development. Pharmacol. Biochem. Behav. 58, 1075-1082.
20. McLaughlin, P. J., Tobias, S. W., Lang, C. M., and Zagon, I. S. (1997b). Chronic exposure to the opioid antagonist naltrexone during pregnancy: Maternal and offspring effects. Physiol. Behav. 62, 501-508.
21. Mombaerts, P. (1999). Seven-transmembrane proteins as odorant and chemosensory receptors. Science 286, 707-711.
22. Raffa, R. B., Martinez, R. P., and Connelly, C. D. (1994). G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception. Eur. J. Pharmacol. 258, R5-R7.
23. Rius, R. A., Barg, J., Bem, W. T., Coscia, C. J., and Loh, Y. P. (1991). The prenatal development profile of expression of opioid peptides and receptors in the mouse brain. Brain Res. Dev. Brain Res. 58, 237-241.
24. Rossi, G. C., Standifer, K. M., and Pasternak, G W. (1995). Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci. Lett. 198, 99-102.
25. Sanchez-Blazquez, P., and Garzon, J. (1992). Intracerebroventricular injection of antibodies directed against Gs alpha enhances the supraspinal antinociception induced by morphine, beta-endorphin and clonidine in mice. Life Sci. 51, L237-L242.
26. Sanchez-Blazquez, P., and Garzon, J. (1993). Delta-opioid supraspinal antinociception in mice is mediated by Gi3 transducer proteins. Life Sci. 53, L129-L134.
27. Sanchez-Blazquez, P., Garcia-Espana, A., and Garzon, J. (1995). In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists. J. Pharmacol. Exp. Ther. 275, 1590-1596.
28. Sanchez-Blazquez, P., Juarros, J. L., Martinez-Pena, Y., Castro, M. A., and Garzon, J. (1993). Gx/z and Gi2 transducer proteins on mu/delta opioid-mediated supraspinal antinociception. Life Sci. 53, L381-L386.
29. Schuller, A. G., King, M. A., Zhang, J., Bolan, E., Pan, Y. X., Morgan, D. J., Chang, A., Czick, M. E., Unterwald, E. M., Pasternak, G. W., and Pintar, J. E. (1999). Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat. Neurosci. 2, 151-156.
30. Seatriz, J. V., and Hammer, R. P., Jr. (1993). Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res. Bull. 30, 523-527.
31. Sim, L. J., and Childers, S. R. (1997). Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5′-O-(gamma-thio)- triphosphate binding in guinea pig brain. J. Comp. Neurol. 386, 562-572.
32. Sim, L. J., Selley, D. E., andChilders, S. R. (1995). In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. USA 92, 7242-7246.
33. Simonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., and Kieffer, B. L. (1998). Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. EMBO J. 17, 886-897.
34. Standifer, K. M., Rossi, G. C., and Pasternak, G. W. (1996). Differential blockade of opioid analgesia by antisense oligode-oxynucleotides directed against various G protein alpha subunits. Mol. Pharmacol. 50, 293-298.
35. Traynor, J. R., and Nahorski, S. R. (1995). Modulation by mu-opioid agonists of guanosine-5′-O-(3- [35S]thio)triphosphate binding to membranes from human neuroblastoma SH- SY5Y cells. Mol. Pharmacol. 47, 848-854.
36. Zagon, I. S. (1987). Endogenous opioids, opioid receptors, and neuronal development. [Review] [32 refs]. NIDA Res. Monogr. 78, 61-71.
37. Zagon, I. S., and McLaughlin, P. J. (1977). Morphine and brain growth retardation in the rat. Pharmacology 15, 276-282.
38. Zagon, I. S., and McLaughlin, P. J. (1978). Perinatal methadone exposure and its influence on the behavioral ontogeny of rats. Pharmacol. Biochem. Behav. 9, 665-672.
39. Zagon, I. S., and McLaughlin, P. J. (1981). Withdrawal-like symptoms in young and adult rats maternally exposed to methadone. Pharmacol. Biochem. Behav. 15, 887-894.
40. Zagon, I. S., and McLaughlin, P. J. (1983). Increased brain size and cellular content in infant rats treated with an opiate antagonist. Science 221, 1179-1180.
41. Zagon, I. S., and McLaughlin, P. J. (1985). Naltrexone's influence on neurobehavioral development. Pharmacol. Biochem. Behav. 22, 441-448.
42. Zagon, I. S., and McLaughlin, P. J. (1987). Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res. 412, 68-72.
43. Zagon, I. S., McLaughlin, P. J., and Thompson, C. I. (1979a). Development of motor activity in young rats following perinatal methadone exposure. Pharmacol. Biochem. Behav. 10, 743-749.
44. Zagon, I. S., McLaughlin, P. J., and Thompson, C. I. (1979b). Learning ability in adult female rats perinatally exposed to methadone. Pharmacol. Biochem. Behav. 10, 889-894.
45. Zagon, I. S., Tobias, S. W., Hytrek, S. D., and McLaughlin, P. J. (1998). Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors. Pharmacol. Biochem. Behav. 59, 201-207.
46. Zhu, Y., Hsu, M. S., and Pintar, J. E. (1998). Developmental expression of the mu, kappa, and delta opioid receptor mRNAs in mouse. J. Neurosci. 18, 2538-2549.
47. Zhu, Y., King, M. A., Schuller, A. G., Nitsche, J. F., Reidl, M., Elde, R. P., Unterwald, E., Pasternak, G. W., and Pintar, J. E. (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24, 243-252.